Abstract:Protein post-translational modifications (PTMs) are chemical modifications of a protein after its translation. Owing to its play an important role in deep understanding of various biological processes and the development of effective drugs, PTM site prediction have become a hot topic in bioinformatics. Recently, many online tools are developed to prediction various types of PTM sites, most of which are based on local sequence and some biological information. However, few of existing tools consider the relation… Show more
“…In order to determine post translation modifications (PTMs) in ACE2, the protein sequence was submitted to PTM-ssMP server, which combines the submitted sequence and site specific modification profile to predict PTM sites in mammalian protein (Liu et al, 2018). Since, glycosylation is the most abundant and diverse posttranslational modification of proteins, therefore, we further determined the O-glycosylation sites in ACE2 using NetOGlyc 4.0 Server which specifically predict the GalNAc-type O-glycosylation site, unique to Ser and Thr (Steentoft et al, 2013).…”
Section: Post Translation Modifications Predictionsmentioning
confidence: 99%
“…Since, experimental methods are high-cost and time-consuming, therefore, it is necessary to theoretically predict PTMs site on protein to be expressed heterologously. PTM-ssMP, which predict PTMs sites on human protein based on local sequence and site specific modification profile (Liu et al, 2018). ACE2 analysis through PTM-ssMP server predicted ubiquitination at position 74 and 304, phosphorylation at 606 and O-glycosylation at 720 residue position.…”
The current pandemic of Covid-19 caused by SARS-CoV-2 is continued to spread globally and no potential drug or vaccine against it is available. Spike (S) glycoprotein is the structural protein of SARS-CoV-2 located on the envelope surface, involve in interaction with angiotensin converting enzyme 2 (ACE2), a cell surface receptor, followed by entry into the host cell. Thereby, blocking the S glycoprotein through potential inhibitor may interfere its interaction with ACE2 and impede its entry into the host cell. Here, we present a truncated version of human ACE2 (tACE2), comprising the N terminus region of the intact ACE2 from amino acid position 21-119, involved in binding with receptor binding domain (RBD) of SARS-CoV-2. We analyzed the in-silico potential of tACE2 to compete with intact ACE2 for binding with RBD. The protein-protein docking and molecular dynamic simulation showed that tACE2 has higher binding affinity for RBD and form more stabilized complex with RBD than the intact ACE2. Furthermore, prediction of tACE2 soluble expression in E. coli makes it a suitable candidate to be targeted for Covid-19 therapeutics. This is the first MD simulation based findings to provide a high affinity protein inhibitor for SARS-CoV-2 S glycoprotein, an important target for drug designing against this unprecedented challenge.
“…In order to determine post translation modifications (PTMs) in ACE2, the protein sequence was submitted to PTM-ssMP server, which combines the submitted sequence and site specific modification profile to predict PTM sites in mammalian protein (Liu et al, 2018). Since, glycosylation is the most abundant and diverse posttranslational modification of proteins, therefore, we further determined the O-glycosylation sites in ACE2 using NetOGlyc 4.0 Server which specifically predict the GalNAc-type O-glycosylation site, unique to Ser and Thr (Steentoft et al, 2013).…”
Section: Post Translation Modifications Predictionsmentioning
confidence: 99%
“…Since, experimental methods are high-cost and time-consuming, therefore, it is necessary to theoretically predict PTMs site on protein to be expressed heterologously. PTM-ssMP, which predict PTMs sites on human protein based on local sequence and site specific modification profile (Liu et al, 2018). ACE2 analysis through PTM-ssMP server predicted ubiquitination at position 74 and 304, phosphorylation at 606 and O-glycosylation at 720 residue position.…”
The current pandemic of Covid-19 caused by SARS-CoV-2 is continued to spread globally and no potential drug or vaccine against it is available. Spike (S) glycoprotein is the structural protein of SARS-CoV-2 located on the envelope surface, involve in interaction with angiotensin converting enzyme 2 (ACE2), a cell surface receptor, followed by entry into the host cell. Thereby, blocking the S glycoprotein through potential inhibitor may interfere its interaction with ACE2 and impede its entry into the host cell. Here, we present a truncated version of human ACE2 (tACE2), comprising the N terminus region of the intact ACE2 from amino acid position 21-119, involved in binding with receptor binding domain (RBD) of SARS-CoV-2. We analyzed the in-silico potential of tACE2 to compete with intact ACE2 for binding with RBD. The protein-protein docking and molecular dynamic simulation showed that tACE2 has higher binding affinity for RBD and form more stabilized complex with RBD than the intact ACE2. Furthermore, prediction of tACE2 soluble expression in E. coli makes it a suitable candidate to be targeted for Covid-19 therapeutics. This is the first MD simulation based findings to provide a high affinity protein inhibitor for SARS-CoV-2 S glycoprotein, an important target for drug designing against this unprecedented challenge.
“…Where experimental data are lacking, the predictive power of bioinformatics can be harnessed to guide experimental research. A variety of models for predicting PTM sites on protein substrates have been developed [ 36 ], some of which were applicable to parasitic protozoa. In particular, algorithms based on amino acid sequence motifs [ 36 , 37 ], protein secondary structure [ 38 , 39 ], or a combination of both [ 40 ], have been devised to determine SUMOylation sites.…”
Section: Introduction: When Parasitic Protozoa Met Ublsmentioning
confidence: 99%
“…A variety of models for predicting PTM sites on protein substrates have been developed [ 36 ], some of which were applicable to parasitic protozoa. In particular, algorithms based on amino acid sequence motifs [ 36 , 37 ], protein secondary structure [ 38 , 39 ], or a combination of both [ 40 ], have been devised to determine SUMOylation sites. Enabled by the release of protozoan proteomic and genomic datasets over the last two decades [ 41 , 42 , 43 ], computational approaches have been instrumental in identifying putative Ubls and enzymes mediating Ubl cascades in these organisms based on sequence and structural similarity to relevant conserved domains [ 19 , 20 , 21 , 22 ].…”
Section: Introduction: When Parasitic Protozoa Met Ublsmentioning
Post-translational protein regulation allows for fine-tuning of cellular functions and involves a wide range of modifications, including ubiquitin and ubiquitin-like modifiers (Ubls). The dynamic balance of Ubl conjugation and removal shapes the fates of target substrates, in turn modulating various cellular processes. The mechanistic aspects of Ubl pathways and their biological roles have been largely established in yeast, plants, and mammalian cells. However, these modifiers may be utilised differently in highly specialised and divergent organisms, such as parasitic protozoa. In this review, we explore how these parasites employ Ubls, in particular SUMO, NEDD8, ATG8, ATG12, URM1, and UFM1, to regulate their unconventional cellular physiology. We discuss emerging data that provide evidence of Ubl-mediated regulation of unique parasite-specific processes, as well as the distinctive features of Ubl pathways in parasitic protozoa. We also highlight the potential to leverage these essential regulators and their cognate enzymatic machinery for development of therapeutics to protect against the diseases caused by protozoan parasites.
“…Accordingly, methods for bioinformatics were developed to predict PTM sites in proteins. Liu et al developed a powerful webserver called PTM-ssMP to identify PTM sites by using protein sequence information 14 . The webserver provides nine kinds of PTM prediction and is freely available at http://bioinformatics.ustc.edu.cn/PTM-ssMP/index/ .…”
This special issue covers a wide range of topics in computational biology, such as database construction, sequence analysis and function prediction with machine learning methods, disease-related diagnosis, drug-target and drug discovery, and electronic health record system construction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.